Pavel Svítil

Pavel Svítil has extensive work experience in the pharmaceutical industry. Pavel is currently the Co-Founder of Medevio, a company they founded in 2020. Previously, they co-founded and served as the CEO of Cogvio, a successful technological company focused on developing B2B digital tools for data-driven decision making in the pharmaceutical industry. In this role, they provided leadership and executive oversight throughout all stages of the startup's growth on a global scale.

Prior to Cogvio, Pavel worked at PharmInvent, where they held multiple roles. Pavel served as the Associate Director and Head of Benefit-Risk Management Unit from September 2015 to October 2017. Pavel also worked as a Project Manager from February 2014 to August 2015 and as the Contract EU QPPV from September 2016 to September 2017. Additionally, Pavel worked at Pierre Fabre as a Pharmacovigilance Expert and PV Consultant on a contract basis from April 2016 to July 2016.

Pavel's earlier experience includes working at SOTIO as an Assistant to the Clinical Research Associate on a part-time basis from June 2012 to December 2012.

Pavel Svítil has a diverse education history. Pavel began their academic journey at Charles University, where they pursued a Doctor of Medicine (M.D.) degree in the field of Medicine from 2006 to 2012. During this time, they gained a strong foundation in the medical field.

In 2011, Pavel Svítil briefly studied at The University of Freiburg, focusing on Medizin as their field of study. Though the exact duration of their time at this institution is not specified, it can be inferred that it was a short-term educational experience.

After completing their medical degree, Pavel Svítil continued their studies at Charles University, this time as a postgraduate student in the field of Neuroscience. Pavel pursued this program from 2012 to 2014, deepening their knowledge and expertise in the neurological sciences.

Parallel to their postgraduate studies, Pavel Svítil also pursued studies at Honors Academia - University of Economics, Prague. From 2013 to 2015, they engaged in a comprehensive program encompassing leadership, management, marketing, human resources, and soft skills. Although a specific degree is not mentioned in relation to this period, it is evident that Pavel Svítil aimed to develop a well-rounded skill set beyond their medical and neuroscience education.

Overall, Pavel Svítil's education history demonstrates their commitment to both medicine and neuroscience, as well as their enthusiasm for expanding their knowledge to areas such as leadership and management.